Rights and permissions
About this article
Cite this article
Early switch from IV to oral cephalosporins is cost saving. Pharmacoecon. Outcomes News 33, 10–11 (1995). https://doi.org/10.1007/BF03309671
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309671